High-throughput biochemical phenotyping of SHP2 variants reveals the molecular basis of diseases and allosteric drug inhibition
Albert A. Lee, Daniel Alexander Mokhtari, Emily D. Egan…·Polly Morrell Fordyce
This study uses high-throughput biochemical assays to analyze SHP2 variants, revealing that dysregulated autoinhibition drives disease and that allosteric inhibitors stabilize a partially active conformation.